Churchill Capital XI Stock Price, News & Analysis
Company Description
Churchill Capital Corp XI is a blank-check company, or SPAC, organized to pursue a business combination with one or more operating businesses. The company is a Cayman Islands issuer with securities listed on The Nasdaq Stock Market under the symbol CCXI for its Class A ordinary shares and CCXIW for its warrants.
As a SPAC, Churchill Capital Corp XI does not operate a conventional product or service business before completing a business combination. Its public-company structure centers on the capital raised for an acquisition mandate, the rights of public shareholders, warrant terms, governance arrangements, and the process for identifying and completing a qualifying transaction. The company’s warrants are structured so that each whole warrant is exercisable for one Class A ordinary share at a stated exercise price.
The company’s public disclosures focus on the issuer mechanics typical of a blank-check company, including security structure, shareholder voting matters, capital-structure disclosure, material-event reporting, and board and committee governance. Its operating identity is therefore defined less by commercial revenue lines and more by its SPAC purpose, its Nasdaq-listed securities, and the governance and capital features that apply while it remains a blank-check issuer.
Churchill Capital Corp XI maintains its principal executive office in New York, New York. Its corporate record identifies Cayman Islands jurisdiction, Nasdaq-listed Class A ordinary shares and warrants, and governance disclosures related to board composition and committee assignments.
Stock Performance
Churchill Capital XI (CCXI) stock last traded at $10.24. Over the past 12 months, the stock has lost 0.2%. At a market capitalization of $570.4M, CCXI is classified as a small-cap stock with approximately 55.7M shares outstanding.
CCXI Rankings
Latest News
Churchill Capital XI has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, conferences, earnings, management, clinical trial. View all CCXI news →
SEC Filings
Churchill Capital XI has filed 5 recent SEC filings, including 2 Form 3, 1 Form 10-Q, 1 Form SCHEDULE 13G/A, 1 Form 10-K. The most recent filing was submitted on May 13, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CCXI SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Churchill Capital XI (CCXI) currently stands at 2.7 thousand shares, up 69.8% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has increased by 110.4%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Churchill Capital XI (CCXI) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
CCXI Company Profile & Sector Positioning
Churchill Capital XI (CCXI) operates in the Shell Companies industry within the broader Blank Checks sector and is listed on the NASDAQ. In monthly performance, the stock ranks #1,817 among all tracked companies.
Investors comparing CCXI often look at related companies in the same sector, including Adma Biologics (ADMA), Mirum Pharmaceuticals (MIRM), Protagonist Ther (PTGX), Ascentage Pharma Group International (AAPG), and Zai Lab Limited (ZLAB). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CCXI's relative position within its industry.